Mode
Text Size
Log in / Sign up
N/A N=801 Randomized Triple-blind Prevention

U01 CRC Project for Vietnamese Americans

Colorectal Cancer

Enrolled (actual)
801
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Colorectal Cancer Screening Rate — 333; 162 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
A Multilevel CBPR Intervention (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
Temple University
Primary completion
Apr 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Colorectal Cancer Screening Rate
333; 162

Summary

Colorectal cancer (CRC) is the second most commonly diagnosed cancer and the third highest cause of mortality in Vietnamese and Asian Americans. CRC incidence is rising rapidly in Vietnamese Americans, but they have among the lowest rates of CRC screening (14%) and are more likely to be diagnosed with advanced stage disease, which is highly preventable. Over 85% of Vietnamese Americans in our region (PA, NJ and NYC) are foreign-born with limited English proficiency, have low SES, and live in economically disadvantaged neighborhoods. Many lack knowledge about CRC risks and screening benefits and have limited access to culturally appropriate preventive care. Center for Asian Health, Temple University will be working with Vietnamese CBOs to address their critical health disparities. The investigators will test the hypothesis that the proposed multilevel CRC intervention will yield higher CRC screening rates compared to the control at 12-month follow-up. This project represents the first large-scale community-based randomized controlled trial of a multilevel, culturally-appropriate intervention to increase CRC screening among underserved Vietnamese. If effective, this innovative CRC intervention can be used as a model program that has potential impact, generalizability and sustainability in Asian American and other underserved ethnic communities.

Eligibility Criteria

Inclusion Criteria

  • self-identified Vietnamese ethnicity,
  • age 50 and above,
  • accessible by cell telephone,
  • presence in the same geographic study area for a period of one year (to minimize participant attrition);
  • not enrolled in any CRC intervention (to prevent a potential program impact),
  • do not have the colorectal polyp, CRC cancer or a family history of CRC (first-degree relative),
  • non-adherent to CRC screening guidelines (never had CRC screening or are overdue for screening).

Exclusion Criteria

  • enrolled in any CRC intervention (to prevent a potential program impact)
  • have the colorectal polyp, CRC cancer or a family history of CRC
  • had CRC screening or adherent to CRC screening guidelines
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03413605). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search